Evidence map›Paper›PMID 39500853›Full record

ArticleMedical & biological engineering & computing2025

Research on imaging biomarkers for chronic subdural hematoma recurrence.

Liyang Wu, Yvmei Zhu, Qiuyong Huang, Shuchao Chen, Haoyang Zhou, Zihao Xu, Bo Li, Hongbo Chen, Junhui Lv

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liyang WuSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Yvmei ZhuSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Qiuyong HuangSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Shuchao ChenSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Haoyang ZhouSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
Zihao XuDepartment of Neurosurgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, 310016, China.
Bo LiDepartment of Neurosurgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, 310016, China.
Hongbo ChenSchool of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China. hongbochen@163.com.
Junhui LvDepartment of Neurosurgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, 310016, China. 3415030@zju.edu.cn.

Funding

Medical Technology and Education of Zhejiang Province of China 2023RC18
6 · The paper itself

Abstract

This study utilizes radiomics to explore imaging biomarkers for predicting the recurrence of chronic subdural hematoma (CSDH), aiming to improve the prediction of CSDH recurrence risk. Analyzing CT scans from 64 patients with CSDH, we extracted 107 radiomic features and employed recursive feature elimination (RFE) and the XGBoost algorithm for feature selection and model construction. The feature selection process identified six key imaging biomarkers closely associated with CSDH recurrence: flatness, surface area to volume ratio, energy, run entropy, small area emphasis, and maximum axial diameter. The selection of these imaging biomarkers was based on their significance in predicting CSDH recurrence, revealing deep connections between postoperative variables and recurrence. After feature selection, there was a significant improvement in model performance. The XGBoost model demonstrated the best classification performance, with the average accuracy improving from 46.82% (before feature selection) to 80.74% and the AUC value increasing from 0.5864 to 0.7998. These results prove that precise feature selection significantly enhances the model's predictive capability. This study not only reveals imaging biomarkers for CSDH recurrence but also provides valuable insights for future personalized treatment strategies.

Indexed as

BiomarkersHematoma, Subdural, ChronicAgedAlgorithmsFemaleHumansMaleMiddle AgedRecurrenceTomography, X-Ray ComputedBiomarkersChronic subdural hematoma (CSDH)CT image analysisImaging biomarkersMachine learningRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.